Search Results - "Prostatic Neoplasms epidemiology"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Source: BMC Cancer
    BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)

  8. 8

    Source: Int J Cancer
    Watts, E L, Martin, R M & the PRACTICAL Consortium 2022, 'Circulating free testosterone and risk of aggressive prostate cancer : Prospective and Mendelian randomisation analyses in international consortia', International Journal of Cancer, vol. 151, no. 7, pp. 1033-1046. https://doi.org/10.1002/ijc.34116
    Watts, E L, Perez-Cornago, A, Fensom, G K, Smith-Byrne, K, Noor, U, Andrews, C D, Gunter, M J, Holmes, M V, Martin, R M, Tsilidis, K K, Albanes, D, Barricarte, A, Bueno-de-Mesquita, H B, Chen, C, Cohn, B A, Dimou, N L, Ferrucci, L, Flicker, L, Freedman, N D, Giles, G G, Giovannucci, E L, Goodman, G E, Haiman, C A, Hankey, G J, Huang, J, Huang, W-Y, Hurwitz, L M, Kaaks, R, Knekt, P, Kubo, T, Langseth, H, Laughlin, G, Le Marchand, L, Luostarinen, T, MacInnis, R J, Mäenpää, H O, Männistö, S, Metter, E J, Mikami, K, Mucci, L A, Olsen, A W, Ozasa, K, Palli, D, Penney, K L, Platz, E A, Rissanen, H, Sawada, N, Schenk, J M, Stattin, P, PRACTICAL Consortium, CRUK, BPC3, CAPS, PEGASUS & Tamakoshi, A 2022, 'Circulating free testosterone and risk of aggressive prostate cancer : Prospective and Mendelian randomisation analyses in international consortia', International Journal of Cancer, vol. 151, no. 7, pp. 1033-1046. https://doi.org/10.1002/ijc.34116

    File Description: application/pdf

  9. 9

    Source: Petersen, S E, Thorsen, L B, Hansen, S, Petersen, P M, Lindberg, H, Moe, M, Petersen, J B, Muren, L P, Høyer, M & Bentzen, L 2022, 'A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients', Acta Oncologica, vol. 61, no. 2, pp. 179-184. https://doi.org/10.1080/0284186X.2021.1979246

  10. 10
  11. 11

    Source: Support Care Cancer

    File Description: 2021_Adam.pdf - application/pdf

  12. 12
  13. 13

    Source: UKGPCS collaborators 2021, 'Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer', Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-020-00311-2
    Karunamuni, R, Walsh, E I, Turner, E L, Lane, J A, Martin, R M, Donovan, J L, Seibert, T M & et al. 2021, 'Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer', Prostate Cancer & Prostatic Diseases, vol. 24, no. 2, pp. 532-541. https://doi.org/10.1038/s41391-020-00311-2
    UKGPCS Collaborators, APCB BioResource (Australian Prostate Cancer BioResource), IMPACT Study Steering Committee and Collaborators, Canary PASS Investigators, Profile Study Steering Committee & PRACTICAL consortium 2021, ' Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer ', Prostate Cancer and Prostatic Diseases, vol. 24, no. 2, pp. 532-541 . https://doi.org/10.1038/s41391-020-00311-2
    UKGPCS Collaborators 2021, 'Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer', Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-020-00311-2
    Prostate Cancer and Prostatic Diseases, vol 24, iss 2
    Karunamuni, R A, Huynh-Le, M-P, Fan, C C, Thompson, W, Eeles, R A, Kote-Jarai, Z, Muir, K, Lophatananon, A, Schleutker, J, Pashayan, N, Batra, J, Grönberg, H, Walsh, E I, Turner, E L, Lane, A, Martin, R M, Neal, D E, Donovan, J L, Hamdy, F C, Nordestgaard, B G, Tangen, C M, MacInnis, R J, Wolk, A, Albanes, D, Haiman, C A, Travis, R C, Stanford, J L, Mucci, L A, West, C M L, Nielsen, S F, Kibel, A S, Wiklund, F, Cussenot, O, Berndt, S I, Koutros, S, Sørensen, K D, Cybulski, C, Grindedal, E M, Park, J Y, Ingles, S A, Maier, C, Hamilton, R J, Rosenstein, B S, Vega, A, Kogevinas, M, Penney, K L, Teixeira, M R, Brenner, H, John, E M, Kaneva, R & UKGPCS collaborators 2021, 'Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer', Prostate Cancer and Prostatic Diseases, vol. 24, pp. 532-541. https://doi.org/10.1038/s41391-020-00311-2

    File Description: application/pdf; Print-Electronic

    Access URL: https://pureadmin.qub.ac.uk/ws/files/227954868/Karunamuni_et_al_2021_AAM.pdf
    https://pubmed.ncbi.nlm.nih.gov/33420416
    https://www.bib.irb.hr/1260882
    https://doi.org/10.1038/s41391-020-00311-2
    https://pure.eur.nl/en/publications/31579db6-eb42-4bb9-bcf0-b481e4698e51
    https://doi.org/10.1038/s41391-020-00311-2
    https://www.ncbi.nlm.nih.gov/pubmed/33420416
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157993
    https://findanexpert.unimelb.edu.au/scholarlywork/1490513-additional-snps-improve-risk-stratification-of-a-polygenic-hazard-score-for-prostate-cancer
    https://christie.aws.openrepository.com/handle/10541/623725
    https://mdanderson.elsevierpure.com/en/publications/additional-snps-improve-risk-stratification-of-a-polygenic-hazard
    https://escholarship.org/uc/item/8mn2q2cr
    https://ora.ox.ac.uk/objects/uuid:55d44a88-812a-4ffa-92c7-8ac766c1b34c
    https://doi.org/10.1038/s41391-020-00311-2
    https://lirias.kuleuven.be/handle/123456789/676675
    https://doi.org/10.1038/s41391-020-00311-2
    https://pure.qub.ac.uk/en/publications/7f3c0f1a-6838-41ce-874b-3718096e0073
    https://research-information.bris.ac.uk/ws/files/268583957/h1_Manuscript_wTables_clean.pdf
    https://hdl.handle.net/1983/4a193f02-0985-429b-a693-06e58b63a293
    https://curis.ku.dk/ws/files/314072222/nihms_1700848.pdf
    https://discovery-pp.ucl.ac.uk/id/eprint/10122739/
    https://escholarship.org/content/qt8mn2q2cr/qt8mn2q2cr.pdf
    https://escholarship.org/uc/item/8mn2q2cr
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157993/pdf/nihms-1700848.pdf
    https://pure.au.dk/portal/en/publications/9c62942c-b0c8-4322-9781-b3942fdf1bab
    https://doi.org/10.1038/s41391-020-00311-2

  14. 14

    Source: Int J Cancer
    Dipòsit Digital de la UB
    Universidad de Barcelona
    Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
    instname
    RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
    Perez-Cornago, A, Huybrechts, I, Appleby, P N, Schmidt, J A, Crowe, F L, Overvad, K, Tjønneland, A, Kühn, T, Katzke, V, Trichopoulou, A, Karakatsani, A, Peppa, E, Grioni, S, Palli, D, Sacerdote, C, Tumino, R, Bueno-de-Mesquita, H B, Larrañaga, N, Sánchez, M-J, Quirós, J R, Ardanaz, E, Chirlaque, M-D, Agudo, A, Bjartell, A, Wallström, P, Chajes, V, Tsilidis, K K, Aune, D, Riboli, E, Travis, R C & Key, T J 2020, 'Intake of Individual Fatty Acids and Risk of Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition', International Journal of Cancer, vol. 146, no. 1, pp. 44-57. https://doi.org/10.1002/ijc.32233
    Perez-Cornago, A, Huybrechts, I, Appleby, P N, Schmidt, J A, Crowe, F L, Overvad, K, Tjønneland, A, Kühn, T, Katzke, V, Trichopoulou, A, Karakatsani, A, Peppa, E, Grioni, S, Palli, D, Sacerdote, C, Tumino, R, Bueno-de-Mesquita, H B, Larrañaga, N, Sánchez, M-J, Quirós, J R, Ardanaz, E, Chirlaque, M-D, Agudo, A, Bjartell, A, Wallström, P, Chajes, V, Tsilidis, K K, Aune, D, Riboli, E, Travis, R C & Key, T J 2020, 'Intake of individual fatty acids and risk of prostate cancer in the European prospective investigation into cancer and nutrition', International Journal of Cancer, vol. 146, no. 1, pp. 44-57. https://doi.org/10.1002/ijc.32233

    File Description: application/pdf

  15. 15

    Source: World J Urol

  16. 16

    Source: J Cancer Surviv
    Hartung, T J, Moustsen, I R, Larsen, S B, Wreford Andersen, E A, Suppli, N P, Johansen, C, Tjønneland, A, Friberg, A S, Kjær, S K, Brasso, K, Kessing, L V, Mehnert, A & Dalton, S O 2021, ' Antidepressant prescriptions and associated factors in men with prostate cancer and their female partners ', Journal of Cancer Survivorship, vol. 15, pp. 536–545 . https://doi.org/10.1007/s11764-020-00947-y

    File Description: application/pdf

  17. 17

    Source: J Cancer Res Clin Oncol

    File Description: application/pdf

  18. 18
  19. 19
  20. 20